Autosomal dominant inheritance of left ventricular outflow tract obstruction

American Journal of Medical Genetics

Volumn 134 A, Issue 2, 2005, Pages 171-179

  Wessels, Marja W ^a   Berger, Rolf M F ^b   Frohn Mulder, Ingrid M E ^b   Roos Hesselink, Jolien W ^a   Hoogeboom, Jeanette J M ^a   Mancini, Grazia S ^a   Bartelings, Margot M ^c   De Krijger, Ronald ^a   Wladimiroff, Jury W ^a   Niermeijer, Martinus F ^a   Grossfeld, Paul ^d   Willems, Patrick J ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RADY CHILDREN'S HOSPITAL   (United States)

^e Genetic Diagnostics Belgium   (Belgium)

Author keywords

Autosomal dominant; Left ventricular outflow tract obstruction; LVOTO; Prenatal diagnosis

Indexed keywords

ADULT; AORTA ARCH ANOMALY; AORTA COARCTATION; AORTA VALVE DISEASE; AORTA VALVE STENOSIS; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; ECHOCARDIOGRAPHY; FAMILY; FEMALE; FETUS; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARDIOVASCULAR ABNORMALITIES; FAMILY HEALTH; FEMALE; GENES, DOMINANT; HUMANS; MALE; MICE; PEDIGREE; REVIEW LITERATURE; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 20144388451     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.30601     Document Type: Article

References (78)

1. Abu-Issa R, Smyth G, Smoak I, Yamamura K, Meyers EN. 2002. Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development 129:4613-4625.
2. Allan LD, Sharland G, Tynan MJ. 1989. The natural history of the hypoplastic left heart syndrome. Int J Cardiol 25:341-343.
3. Andelfinger G, Tapper AR, Welch RC, Vanoye CG, George AL Jr, Benson DW. 2002. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 71: 663-668.
4. Anderson NG, Brown J. 1991. Normal size left ventricle on antenatal scan in lethal hypoplastic left heart syndrome. Pediatr Radiol 21:436-437.
5. Beekman RH, Robinow M. 1985. Coarctation of the aorta inherited as an autosomal dominant trait. Am J Cardiol 56:818-819.
6. Biben C, Weber R, Kesteven S, Stanley E, McDonald L, Elliott DA, Barnett L, Koentgen F, Robb L, Feneley M, Harvey RP. 2000. Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2.5. Circ Res 87:888-895.
7. Boon AR, Roberts DF. 1976. A family study of coarctation of the aorta. J Med Genet 13:420-433.
8. Boughman JA. 1991. Variations of familial risks of congenital cardiovascular malformations (CCVM): Higher risk in left flow defect families. Am J Hum Genet Suppl 49(4):465.
9. Boughman JA, Berg KA, Astemborski JA, Clark EB, McCarter KJ, Rubin JD, Ferencz C. 1987. Familial risks of congenital heart defect assessed in a population-based epidemiologic study. Am J Med Genet 26:839-849.
10. Brice G, Mansour S, Bell R, Collin JR, Child AH, Brady AF, Sarfarazi M, Burnand KG, Jeffery S, Mortimer P, Murday VA. 2002. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet 39: 478-483.
11. Brownell LG, Shokeir MHK. 1976. Inheritance of hypoplastic left heart syndrome (HLHS): Further observations. Clin Genet 9:245-249.
12. Bruel H, Poinsot J, Chabrolle JP, Layet V. 1999. Association of aplasia cutis congenita with coarctation of the aorta: A coincidence? Arch Pediatr 6:1193-1195.
13. Bruneau BG, Logan M, Davis N, Levi T, Tabin CJ, Seidman JG, Seidman CE. 1999. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev Biol 211:100-108.
14. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE, Seidman JG. 2001. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106:709-721.
15. Chen B, Bronson RT, Klaman LD, Hampton TG, Wang JF, Green PJ, Magnuson T, Douglas PS, Morgan JP, Neel BG. 2000. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet 24:296-299.
16. Clouthier DE, Hosoda K, Richardson JA, Williams SC, Yanagisawa H, Kuwaki T, Kumada M, Hammer RE, Yanagisawa M. 1998. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development 125:813-824.
17. Consevage MW, Seip JR, Belchis DA, Davis AT, Baylen BG, Rogan PK. 1996. Association of a mosaic chromosomal 22q11 deletion with hypoplastic left heart syndrome. Am J Cardiol 77:1023-1025.
18. Cornel G, Sharratt GP, Virmani S, Resales T, Lacson A. 1987. Familial coarctation of the aortic arch with bilateral ptosis: a new syndrome? J Pediatr Surg 22:724-726.
19. Cough JH. 1961. Coarctation of the aorta in father and son. Brit J Radiol 34:670-672.
20. Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M. 2004. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Dev Biol 271:263-271.
21. Dallapiccola B, Giannotti A, Marino B, Digilio C, Obregon G. 1992. Familial aplasia cutis congenita and coarctation of the aorta. Am J Med Genet 43:762-763.
22. Danford DA, Cronican P. 1992. Hypoplastic left heart syndrome: progression of left ventricular dilation and dysfunction to left ventricular hypoplasia in utero. Am Heart J 123:1712-1713.
23. Dasgupta C, Martinez AM, Zuppan CW, Shah MM, Bailey LL, Fletcher WH. 2001. Identification of connexin43 (alpha1) gap junction gene mutations in patients with hypoplastic left heart syndrome by denaturing gradient gel electrophoresis (DGGE). Mutat Res 479:173-186.
24. Digilio MC, Marino B, Toscano A, Giannotti A, Dallapiccola B. 2001. Congenital heart defects in Kabuki syndrome. Am J Med Genet 100: 269-274.
25. Elliott DA, Kirk EP, Yeoh T, Chandar S, McKenzie F, Taylor P, Grossfeld P, Fatkin D, Jones O, Hayes P, Feneley M, Harvey RP. 2003. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. J Am Coll Cardiol 41:2072-2076.
26. Eronen M, Peippo M, Hiippala A, Raatikka M, Arvio M, Johansson R, Kahkonen M. 2002. Cardiovascular manifestations in 75 patients with Williams syndrome. J Med Genet 39:554-558.
27. Feiner L, Webber AL, Brown CB, Lu MM, Jia L, Feinstein P, Mombaerts P, Epstein JA, Raper JA. 2001. Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption. Development 128:3061-3070.
28. Ferencz C, Rubin JD, Loffredo CA, Magee CA. 1993. Epidemiology of congenital heart disease: The Baltimore-Washington Infant study, 1981-1989. Mt. Kisco, NY: Futura Publishing Co. 45p.
29. Firulli AB, McFadden DG, Lin Q, Srivastava D, Olson EN. 1998. Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1. Nat Genet 18:266-270.
30. Fishman NH, Hof RB, Rudolph AM, Heymann MA. 1978. Models of congenital heart defects in fetal lambs. Circulation 58:354-364.
31. Galvin KM, Donovan MJ, Lynch CA, Meyer RI, Paul RJ, Lorenz JN, Fairchild-Huntress V, Dixon KL, Dunmore JH, Gimbrone MA Jr, Falb D, Huszar D. 2000. A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 24:171-174.
32. Gerboni S, Sabatino G, Mingarelli R, Dallapiccola XX. 1993. Coarctation of the aorta, interrupted aortic arch and hypoplastic left heart syndrome in three generations. J Med Genet 30:328-329.
33. Goldmuntz E, Geiger E, Benson DW. 2001. NKX2.5 mutations in patients with tetralogy of fallot. Circulation 104:2565-2568.
34. Gong W, Gottlieb S, Collins J, Blescia A, Dietz H, Goldmuntz E, McDonald-McGinn DM, Zackai EH, Emanuel BS, Driscoll DA, Budarf ML. 2001. Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet 38:e45.
35. Grobman W, Pergament E. 1996. Isolated hypoplastic left heart syndrome in three siblings. Obstet Gynaecol 88:673-675.
36. Grossfeld PD. 1999. The genetics of hypoplastic left heart syndrome. Cardiol Young 9:627-632.
37. Grossfeld PD, Mattina T, Lai Z, Favier R, Jones KL, Cotter F, Jones C. 2004. The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet 129A(1):51-61.
38. Harh JY, Paul MH, Gallen WJ, Friedberg DZ, Kaplan S. 1973. Experimental production of hypoplastic left heart syndrome in the chick embryo. Am J Cardiol 31:51-56.
39. Hofstra RMW, Valdenaire O, Arch E, Osinga J, Kroes H, Loffler B-M, Hamosh A, Meijers C, Buys CHCM. 1999. A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction. Am J Hum Genet 64:304-308.
40. Huang F, Wagner M, Siddiqui MA. 2004. Ablation of the CLP-1 gene leads to down-regulation of the HAND1 gene and abnormality of the left ventricle of the heart and fetal death. Mech Dev 121:559-572.
41. Jerome LA, Papaioannou VE. 2001. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 27:286-291.
42. Johnson EN, Lee YM, Sander TL, Rabkin E, Schoen FJ, Kaushal S, Bischoff J. 2002. NFATc1 mediates vascular endothelial growth factor (VEGF)-induced proliferation in human pulmonary valve endothelial cells. J Biol Chem 278:1686-1692.
43. Kurihara Y, Kurihara H, Oda H, Maemura K, Nagai R, Ishikawa T, Yazaki Y. 1995. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest 96:293-300.
44. Lee TC, Zhao YD, Courtman DW, Stewart DJ. 2000. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 101:2345-2348.
45. Li DY, Faury G, Taylor DG, Davis EC, Boyle WA, Mecham RP, Stenzel P, Boak B, Keating MT. 1998. Novel arterial pathology in mice and humans hemizygous for elastin. J Clin Invest 102:1783-1787.
46. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland H, Scambler PJF, Bradley A, Baldini A. 2001. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410:97-101.
47. Liu XZ, Xia XJ, Adams J, Chen ZY, Welch KO, Tekin M, Ouyang XM, Kristiansen A, Pandya A, Balkany T, Arnos KS, Nance WE. 2001. Mutations in GJA1 (connexin 43) are associated with non-syndromic autosomal recessive deafness. Hum Mol Genet 10:2945-2951.
48. Loffredo CA, Chokkalingam A, Sill AM, Boughman JA, Clark EB, Scheel J, Brenner JI. 2004. Prevalence of congenital cardiovascular malformations among relatives of infants with hypoplastic left heart, coarctation of the aorta, and d-transposition of the great arteries. Am J Med Genet 124:225-230.
49. Marino B, Digilio MC, Toscano A, Giannotti A, Dallapiccola B. 1999. Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr 135:703-706.
50. Mazzanti L, Cacciari E. 1998. Congenital heart disease in patients with Turner's syndrome. Italian Study Group for Turner Syndrome (ISGTS). J Pediatr 133:688-692.
51. McDonald K, Maurer BJ. 1989. Familial aortic valve disease: evidence for a genetic influence? Eur Heart J 10:676-677.
52. McElhinney DB, Krantz ID, Bason L, Piccoli DA, Emerick KM, Spinner NB, Goldmuntz E. 2002. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 106:2567-2574.
53. McElhinney DB, Geiger E, Blinder J, Woodrow Benson D, Goldmuntz E. 2003. Nkx2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 42:1650-1655.
54. Menahem S. 1990. Familial aggregation of defects of the left-sided structures of the heart. Int J Cardiol 29:239-240.
55. Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Lu MM, Xavier RJ, Demay MB, Russell RG, Factor S, Tokooya K, Jore BS, Lopez M, Pandita RK, Lia M, Carrion D, Xu H, Schorle H, Kobler JB, Scambler P, Wynshaw-Boris A, Skoultchi AI, Morrow BE, Kucherlapati R. 2001. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619-629.
56. Nishimura DY, Swiderski RE, Alward WL, Searby CC, Patil SR, Bennet SR, Kanis AB, Gastier JM, Stone EM, Sheffield VC. 1998. The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25. Nat Genet 19:140-147.
57. Nora JJ, Nora AH. 1988. Update on counseling the family with a first-degree relative with a congenital heart defect. Am J Med Genet 29:137-142.
58. Nordenberg DF, Hanna B, Fouron JC, Kaloustian VM. 1989. Atrial septal defect, ventri-cular septal defect and coarctation of the aorta. Am J Med Genet 32:182-183.
59. Paznekas WA, Boyadjiev SA, Shapiro RE, Daniels O, Wollnik B, Keegan CE, Innis JW, Dinulos MB, Christian C, Hannibal MC, Jabs EW. 2003. Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. Am J Hum Genet 72:408-418.
60. Penny LA, Dell'Aquila M, Jones MC, Bergoffen J, Cunniff C, Fryns J-P, Grace E, Graham JM Jr, Kousseff B, Mattina T, Syme J, Voullaire L, Zelante L, Zenger-Hain J, Jones OW, Evans GA. 1995. Clinical and molecular characterization of patients with distal 11q deletions. Am J Hum Genet 56:676-683.
61. Phillips HM, Renforth GL, Spalluto C, Hearn T, Curtis AR, Craven L, Havarani B, Clement-Jones M, English C, Stumper O, Salmon T, Hutchinson S, Jackson MS, Wilson DI. 2002. Narrowing the critical region within 11q24-qter for hypoplastic left heart and identification of a candidate gene, JAM3, expressed during cardiogenesis. Genomics 79:475-478.
62. Pivnick EK, Velagaleti GVN, Wilroy RS, Smith ME, Rose SR, Tipton RE, Tharapel AT. 1996. Jacobson syndrome: Report of a patient with severe eye anomalies, growth hormone deficiency, and hypothyroidism associated with deletion 11(q23q25) and review of 52 cases. J Med Genet 33: 772-778.
63. Purandare SM, Ware SM, Kwan KM, Gebbia M, Bassi MT, Deng JM, Vogel H, Behringer RR, Belmont JW, Casey B. 2002. A complex syndrome of left-right axis, central nervous system and axial skeleton defects in Zic3 mutant mice. Development 129:2293-2302.
64. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant J. 1995. Cardiac malformation in neonatal mice lacking connexin43. Science 267:1831-1834.
65. Roberts CS, Roberts WC. 1991. Dissection of the aorta associated with congenital malformation of the aortic valve. J Am Coll Cardiol 17:712-716.
66. Rose V, Gold RJ, Lindsay G, Allen M. 1985. A possible increase in the incidence of congenital heart defects among the offspring of affected parents. J Am Coll Cardiol 6:376-382.
67. Sarkozy A, Conti E, Seripa D, Digilio MC, Grifone N, Tandoi C, Fazio VM, Di Ciommo V, Marino B, Pizzuti A, Dallapiccola B. 2003. Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J Med Genet 40:704-708.
68. Sharland GK, Allan LD. 1992. Normal fetal cardiac measurements derived by cross-sectional echocardiography. Ultrasound Obstet Gynaecol 2:175-181.
69. Shokeir MHK. 1971. Hypoplastic left heart syndrome: An autosomal recessive disorder. Clin Genet 2:7-14.
70. Simon AB, Zloto AE, Perry BL, Sigmann JM. 1974. Familial aspects of coarctation of the aorta. Chest 66:687-689.
71. Sletten LJ, Pierpont ME. 1996. Variation in severity of cardiac disease in Holt-Oram syndrome. Am J Med Genet 65:128-132.
72. Stoll C, Alembik Y, Dott B. 1999. Familial coarctation of the aorta in three generations. Ann Genet 42:174-176.
73. Ware SM, Peng J, Zhu L, Fernbach S, Colicos S, Casey B, Towbin J, Belmont JW. 2004. Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects. Am J Hum Genet 74: 93-105.
74. Winnier GE, Kume T, Deng K, Rogers R, Bundy J, Raines C, Walter MA, Hogan BL, Conway SJ. 1999. Roles for the winged helix transcription factors MF1 and MFH1 in cardiovascular development revealed by nonallelic noncomplementation of null alleles. Dev Biol 213: 418-431.
75. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, Gendron-Maguire M, Rand EB, Weinmaster G, Gridley T. 1999. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8:723-730.
76. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R. 2003. Role of TBX1 in human del22q11.2 syndrome. Lancet 362:1366-1373.
77. Yanagisawa H, Yanagisawa M, Kapur RP, Richardson JA, Williams SC, Clouthier DE, de Wit D, Emoto N, Hammer RE. 1998. Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125:825-826.
78. Zhou HM, Weskamp G, Chesneau V, Sahin U, Vortkamp A, Horiuchi K, Chiusaroli R, Hahn R, Wilkes D, Fisher P, Baron R, Manova K, Basson CT, Hempstead B, Blobel CP. 2004. Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol 24:96-104.